These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 195512)

  • 1. [Comparison of the immunogenic potencies of purified inactivated foot-and-mouth disease virus particles with variable amounts of VP1 protein (author's transl)].
    Bernard S; Grosclaude J; Adamowicz P; Guerche J
    Ann Rech Vet; 1977; 8(1):79-94. PubMed ID: 195512
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antigenic structure of the foot-and-mouth-disease virus. I. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth virus type O1K].
    Surovoĭ AIu; Vol'pina OM; Snetkova EV; Volkova TD; Ivanov VT
    Bioorg Khim; 1988 Oct; 14(10):1352-62. PubMed ID: 2852937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antigenic structure of foot-and-mouth virus. IV. Synthesis and immunogenic properties of new fragments of the VP1 protein of food-and-mouth virus strain A22].
    Iarov AV; Gel'fanov VM; Grechaninova LA; Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Lugovskoĭ AA; Driagalin NN; Ivaniushchenkov VN
    Bioorg Khim; 1989 Sep; 15(9):1193-205. PubMed ID: 2556150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antigenic structure of the foot-and-mouth disease virus. II. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth disease virus type A22].
    Vol'pina OM; Surovoĭ AIu; Ul'iashin VV; Ivanov VT; Chepurkin AV
    Bioorg Khim; 1988 Oct; 14(10):1363-71. PubMed ID: 2852938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antigenic structure of the foot-and-mouth disease virus. III. Immunogenic properties of synthetic peptides of the sequence of the immunodominant region of VP1 proteins of the O1K and A22 strains of foot-and-mouth virus].
    Surovoĭ AIu; Gel'fanov VM; Vol'pina OM; Ivanov VT; Chepurkin AV; Chepurkin AV; Ivaniushchenkov VM; Driagalin NN; Burdov AN
    Bioorg Khim; 1989 Sep; 15(9):1185-92. PubMed ID: 2480134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposome encapsulated subunit (VP1) and virion vaccines against foot-and-mouth disease.
    Vasantha S; Antony A; Lal SM
    Acta Virol; 1987 Mar; 31(2):109-15. PubMed ID: 2886019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of antibody-forming cells by means of local hemolysis in gel (LHG) in mice and pigs after immunization with infectious or inactivated foot-and-mouth disease virus (author's transl)].
    Reda I; Wittmann G; Skoda R
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):119-31. PubMed ID: 4143236
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of the minor polypeptides in the foot-and-mouth disease particle.
    Sangar DV; Rowlands DJ; Cavanagh D; Brown F
    J Gen Virol; 1976 Apr; 31(1):35-46. PubMed ID: 177728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic peptides against foot-and-mouth disease--immunization with VP1-peptides of type O1-Kaufbeuren.
    Liebermann H; Holl U; Reimann I; Nöckler A; Schäfer D; Thalmann G; Dölling R
    Arch Exp Veterinarmed; 1990; 44(6):883-90. PubMed ID: 1966360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Production of purified foot-and-mouth disease virus antigens and the specific sera against them].
    Tekerlekov P; Nikolova E; Vasileva L
    Vet Med Nauki; 1978; 15(6):21-8. PubMed ID: 85363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of laboratory techniques for the evaluation of the antigenic potency of foot-and-mouth disease virus cultures and vaccines.
    Terpstra C; Frenkel S; Straver PJ; Barteling SJ; van Bekkum JG
    Dev Biol Stand; 1976; 35():333-42. PubMed ID: 198304
    [No Abstract]   [Full Text] [Related]  

  • 12. Bacterially expressed antigenic peptide from foot-and-mouth disease virus capsid elicits variable immunologic responses in animals.
    Winther MD; Allen G; Bomford RH; Brown F
    J Immunol; 1986 Mar; 136(5):1835-40. PubMed ID: 3005401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Routine physico-chemical testing of concentrated virulent and inactivated foot-and-mouth disease virus antigens].
    Adamowicz P; Guerche J; Galampoix J; Prunet P
    Dev Biol Stand; 1976; 35():301-10. PubMed ID: 198300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physical chemical measurement of 140S particles of the foot-and-mouth disease virus].
    Fayet MT; Fargeaud D; Louisot P; Stellmann C; Roumiantzeff M
    Ann Inst Pasteur (Paris); 1971 Jul; 121(1):107-18. PubMed ID: 4329751
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antigenic structure of the foot-and-mouth virus. V. Protection of naturally susceptible animals from foot-and-mouth disease using a synthetic peptide].
    Iarov AV; Gel'fanov VM; Grechaninova LA; Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Driagalin NN; Ivaniushchenkov VM
    Bioorg Khim; 1989 Oct; 15(10):1313-7. PubMed ID: 2561049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nature of the antibody response to the foot-and-mouth disease virus particle, its 12S protein subunit and the isolated immunizing polypeptide VP1.
    Cartwright B; Morrell DJ; Brown F
    J Gen Virol; 1982 Dec; 63(2):375-81. PubMed ID: 6296284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenic quality of foot-and-mouth disease virus.
    Strobbe R
    Dev Biol Stand; 1976; 35():311-21. PubMed ID: 198301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological behaviour & antigenicity of mouse passaged & formol inactivated foot & mouth disease virus type Asia-1 in guineapigs.
    Saraswat KC; Sharma KN; Mehrotra PN
    Indian J Exp Biol; 1980 Mar; 18(3):275-8. PubMed ID: 6248457
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of antibodies in the antigenic variability of the foot-and-mouth disease virus].
    Salazhov EL; Avilov VS; Rebenkov AG
    Veterinariia; 1976; (9):31-2. PubMed ID: 186935
    [No Abstract]   [Full Text] [Related]  

  • 20. Purification and immunogenicity of fusion VP1 protein of foot and mouth disease virus.
    Shire SJ; Bock L; Ogez J; Builder S; Kleid D; Moore DM
    Biochemistry; 1984 Dec; 23(26):6474-80. PubMed ID: 6099140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.